Thomas Fischer
Impact in
- Hematology top 0.5%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 45
- Chronic Myeloid Leukemia Treatments 21
- Platelet Disorders and Treatments 16
- Genetics 32
- Chronic Lymphocytic Leukemia Research 24
- Co-authors
- Jan AlmløfPepijn W. H. PinkseGerhard RempePeter MaunzAlexander DrzezgaCarsten KobeAlbert J. BanesMari Tsuzaki
- Journals
- Blood (12 papers)Nuklearmedizin - NuclearMedicine (9 papers)Journal of Clinical Oncology (8 papers)British Journal of Haematology (6 papers)Annals of Hematology (6 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Thomas Fischer
186 papers receiving 8.8k citations
Hit Papers
Peers
Comparison fields: 5 of 172
- Hematology 1.8k
- Genetics 1.0k
- Atomic and Molecular Physics, and Optics 1.4k
- Materials Chemistry 1.9k
- Radiology, Nuclear Medicine and Imaging 850
Countries citing papers authored by Thomas Fischer
This map shows the geographic impact of Thomas Fischer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Fischer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Fischer more than expected).
Fields of papers citing papers by Thomas Fischer
This network shows the impact of papers produced by Thomas Fischer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Fischer. The network helps show where Thomas Fischer may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Fischer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 2 | |
| 6 | 2022 | 25 | |
| 7 | 2021 | 15 | |
| 8 | 2015 | 9 | |
| 9 | 2014 | 18 | |
| 10 | 2014 | 20 | |
| 11 | Entwicklung von Anti-CD30-Radioimmunkonstrukten zur Behandlung des Hodgkin-Lymphoms – Studien an Zellkulturen und Tieren | 2010 | 6 |
| 12 | 2010 | 31 | |
| 13 | 2008 | 2 | |
| 14 | 2007 | 160 | |
| 15 | 2007 | 13 | |
| 16 | 2007 | 43 | |
| 17 | Gezond bewegen in groep 7 en 8 | 2006 | 2 |
| 18 | 2001 | 22 | |
| 19 | 1996 | 17 | |
| 20 | Inventionsprozesse und Unternehmungsentwicklung : die Initiierung von Neuerungsprozessen in Unternehmungen | 1982 | 0 |
About Thomas Fischer
Thomas Fischer is a scholar working on Hematology, Genetics, Radiology, Nuclear Medicine and Imaging, Architecture and Pathology and Forensic Medicine, having authored 202 papers that have together received 9.1k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (24 papers), Chronic Myeloid Leukemia Treatments (21 papers), Radiopharmaceutical Chemistry and Applications (21 papers), Lymphoma Diagnosis and Treatment (18 papers), Platelet Disorders and Treatments (16 papers), Eosinophilic Disorders and Syndromes (12 papers), Blood properties and coagulation (12 papers) and Prostate Cancer Treatment and Research (12 papers). The work is most often cited by research in Hematology (1.8k citations), Genetics (1.0k citations), Atomic and Molecular Physics, and Optics (1.4k citations), Materials Chemistry (1.9k citations) and Radiology, Nuclear Medicine and Imaging (850 citations). Thomas Fischer has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Jan Almløf, Pepijn W. H. Pinkse, Gerhard Rempe, Peter Maunz, Alexander Drzezga, Carsten Kobe, Albert J. Banes, Mari Tsuzaki, Brian E. Brigman and Klaus Schomäcker. Their work appears in journals such as Blood, Nuklearmedizin - NuclearMedicine, Journal of Clinical Oncology, British Journal of Haematology and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.